Prevalence of cardiovascular disease events and determinants in patients with x-linked hypophosphatemia

Prevalence of cardiovascular disease events and determinants in patients with x-linked hypophosphatemia

Bibliographische Detailangaben
Hauptverfasser:	Maronga, C, Javaid, MK, Pinedo Villanueva, R
Format:	Conference item
Sprache:	English
Veröffentlicht:	Springer Nature 2023

Ähnliche Einträge

Prevalence and risk factors of hypertension among patients with X-linked hypophosphatemia
von: Maronga, C, et al.
Veröffentlicht: (2023)

A literature review of the healthcare resource use and productivity burden of X-linked hypophosphatemia
von: Pinedo Villanueva, R, et al.
Veröffentlicht: (2023)

Increased prevalence of overweight and obesity in children with X-linked hypophosphatemia
von: Volha V Zhukouskaya, et al.
Veröffentlicht: (2020-02-01)

Dental management of patients with X-linked hypophosphatemia
von: Bin-Na Lee, et al.
Veröffentlicht: (2017-05-01)

Prevalence and clinical characteristics of X-linked hypophosphatemia in Paraná, southern Brazil
von: Carolina Aguiar Moreira, et al.
Veröffentlicht: (2020-10-01)

Treatment of X-Linked Hypophosphatemia in Children
von: Toshihiro Tajima, et al.
Veröffentlicht: (2022-08-01)

Adult Presentation of X-Linked Hypophosphatemia
von: Nobuaki Ito
Veröffentlicht: (2022-07-01)

Special Issue: “X-Linked Hypophosphatemia”
von: Seiji Fukumoto, et al.
Veröffentlicht: (2023-11-01)

Craniosynostosis in Patients With X‐Linked Hypophosphatemia: A Review
von: Craig F Munns, et al.
Veröffentlicht: (2023-05-01)

FURTHER LOCALIZATION OF THE GENE FOR X-LINKED HYPOPHOSPHATEMIA
von: Read, A, et al.
Veröffentlicht: (1987)

Complications and Treatments in Adult X-Linked Hypophosphatemia
von: Yasuo Imanishi, et al.
Veröffentlicht: (2022-09-01)

X-Linked Hypophosphatemia Transition and Team Management
von: Takuo Kubota
Veröffentlicht: (2022-07-01)

Presentation and Diagnosis of Pediatric X-Linked Hypophosphatemia
von: Kento Ikegawa, et al.
Veröffentlicht: (2023-02-01)

Hereditary X-Linked Hypophosphatemia and Thoracic Myelopathy
von: George Forrest, MD, et al.
Veröffentlicht: (2016-01-01)

Cardiovascular health in pediatric patients with X-linked hypophosphatemia under two years of burosumab therapy
von: Avivit Brener, et al.
Veröffentlicht: (2024-05-01)

Mutational analysis of PHEX gene in X-linked hypophosphatemia.
von: Dixon, P, et al.
Veröffentlicht: (1998)

Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia
von: Forestier-Zhang, L, et al.
Veröffentlicht: (2016)

X-linked hypophosphatemia attributable to pseudoexons of the PHEX gene.
von: Christie, P, et al.
Veröffentlicht: (2001)

Burosumab and Dental Abscesses in Children With X‐Linked Hypophosphatemia
von: Margaux Gadion, et al.
Veröffentlicht: (2022-11-01)

Orthopedic Complications and Management in Children with X-Linked Hypophosphatemia
von: Chikahisa Higuchi
Veröffentlicht: (2022-08-01)

Dental Manifestations and Oral Management of X-Linked Hypophosphatemia
von: Rena Okawa, et al.
Veröffentlicht: (2022-10-01)

Dental health of patients with X-linked hypophosphatemia: A controlled study
von: Amila Larsson, et al.
Veröffentlicht: (2023-03-01)

An adult patient of X-linked hypophosphatemia with joint manifestation mimicking spondylarthritis
von: Chuhan Wang, et al.
Veröffentlicht: (2022-05-01)

Clinical and genetic characteristics of 29 Chinese patients with X-linked hypophosphatemia
von: Tian Xu, et al.
Veröffentlicht: (2022-08-01)

Health-related quality of life of X-linked hypophosphatemia in Spain
von: M. I. Luis Yanes, et al.
Veröffentlicht: (2022-07-01)

The Metabolic Bone Disease X-linked Hypophosphatemia: Case Presentation, Pathophysiology and Pharmacology
von: Jon Vincze, et al.
Veröffentlicht: (2021-06-01)

Pathogenesis of FGF23-Related Hypophosphatemic Diseases Including X-linked Hypophosphatemia
von: Tatsuro Nakanishi, et al.
Veröffentlicht: (2022-06-01)

Evaluation of dental manifestations in X-linked hypophosphatemia using orthopantomography.
von: Rena Okawa, et al.
Veröffentlicht: (2024-01-01)

Insights into the Molecular and Hormonal Regulation of Complications of X-Linked Hypophosphatemia
von: Supriya Jagga, et al.
Veröffentlicht: (2023-03-01)

Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population
von: Enrique Rodríguez-Rubio, et al.
Veröffentlicht: (2021-02-01)

Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium
von: Michaël R. Laurent, et al.
Veröffentlicht: (2021-03-01)

Subgroups of adults with X-linked hypophosphataemia: cluster analysis of patient-reported outcome measures of participants in a UK rare diseases cohort
von: Cole, S, et al.
Veröffentlicht: (2021)

X-linked hypophosphataemia: prevalence and mortality rate within the United Kingdom Clinical Practice Research Datalink
von: Hawley, S, et al.
Veröffentlicht: (2019)

Expression and cloning of the human X-linked hypophosphatemia gene cDNA.
von: Grieff, M, et al.
Veröffentlicht: (1997)

Impact of burosumab on lower limb alignment in children with X-linked hypophosphatemia
von: David B. Frumberg, MD, FAAOS, et al.
Veröffentlicht: (2024-02-01)

Characteristics of oral health of patients with X-linked hypophosphatemia: case reports and literature review
von: Ana Arhar, et al.
Veröffentlicht: (2024-05-01)

Positive Response to One-Year Treatment With Burosumab in Pediatric Patients With X-Linked Hypophosphatemia
von: Silvia Martín Ramos, et al.
Veröffentlicht: (2020-02-01)

Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK
von: Cole, S, et al.
Veröffentlicht: (2023)

Expected benefits and budget impact from a microsimulation model support the prioritisation and implementation of fracture liaison services
von: Pinedo Villanueva, R, et al.
Veröffentlicht: (2023)

Lower limb maltorsion and acetabular deformity in children and adolescents with X-linked hypophosphatemia
von: Alexandra Stauffer, et al.
Veröffentlicht: (2024-09-01)